These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26929941)

  • 1. Increased pertechnetate and radioiodine uptake in the thyroid gland with subacute thyroiditis and concurrent Graves' disease.
    Li L; Sun L; Yu S; Ma C
    Hell J Nucl Med; 2016; 19(1):49-52. PubMed ID: 26929941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pertechnetate thyroid uptake is not always suppressed in patients with subacute thyroiditis.
    Shigemasa C; Teshima S; Taniguchi S; Ueta Y; Mitani Y; Yoshida A
    Clin Nucl Med; 1997 Feb; 22(2):109-14. PubMed ID: 9031769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutoff value of thyroid uptake of (99m)Tc-pertechnetate to discriminate between Graves' disease and painless thyroiditis: a single center retrospective study.
    Uchida T; Suzuki R; Kasai T; Onose H; Komiya K; Goto H; Takeno K; Ishii S; Sato J; Honda A; Kawano Y; Himuro M; Yamada E; Yamada T; Watada H
    Endocr J; 2016; 63(2):143-9. PubMed ID: 26581846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous occurrence of subacute thyroiditis and Graves' disease.
    Hoang TD; Mai VQ; Clyde PW; Shakir MK
    Thyroid; 2011 Dec; 21(12):1397-400. PubMed ID: 22136271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the factors associated with Tc-99m pertechnetate uptake in thyrotoxicosis and graves' disease.
    Kidokoro-Kunii Y; Emoto N; Cho K; Oikawa S
    J Nippon Med Sch; 2006 Feb; 73(1):10-7. PubMed ID: 16538017
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zhao L; Zhang W; Xin Y; Wen Q; Bail L; Guan F; Bin J
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):349-353. PubMed ID: 30413358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease.
    Sekulić V; Rajić M; Vlajković M; Ilić S; Bogićević M; Antić S; Dimić D
    Hell J Nucl Med; 2006; 9(3):173-6. PubMed ID: 17160158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diagnostic Utility of Color Doppler Ultrasonography, Tc-99m Pertechnetate Uptake, and TSH-Receptor Antibody for Differential Diagnosis of Graves' Disease and Silent Thyroiditis: A Comparative Study.
    Zuhur SS; Ozel A; Kuzu I; Erol RS; Ozcan ND; Basat O; Yenici FU; Altuntas Y
    Endocr Pract; 2014 Apr; 20(4):310-9. PubMed ID: 24246346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between peak systolic velocity of the inferior thyroid artery and technetium-99m pertechnetate thyroid uptake in differentiating Graves' disease from thyroiditis.
    Malik SA; Choh NA; Misgar RA; Khan SH; Shah ZA; Rather TA; Shehjar F; Laway BA
    Arch Endocrinol Metab; 2019; 63(5):495-500. PubMed ID: 31482952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99 m sestamibi imaging in patients with subacute thyroiditis.
    Hiromatsu Y; Ishibashi M; Nishida H; Kawamura S; Kaku H; Baba K; Kaida H; Miyake I
    Endocr J; 2003 Jun; 50(3):239-44. PubMed ID: 12940451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transition of subacute thyroiditis to Graves' disease as evidenced by diagnostic imaging.
    Bennedbaek FN; Gram J; Hegedüs L
    Thyroid; 1996 Oct; 6(5):457-9. PubMed ID: 8936671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subacute thyroiditis in a single lobe.
    Sari O; Erbaş B; Erbaş T
    Clin Nucl Med; 2001 May; 26(5):400-1. PubMed ID: 11317018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High pre-therapy [99mTc]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in [131I]iodide therapy in Graves' disease.
    Zantut-Wittmann DE; Ramos CD; Santos AO; Lima MM; Panzan AD; Facuri FV; Etchebehere EC; Lima MC; Tambascia MA; Camargo EE
    Nucl Med Commun; 2005 Nov; 26(11):957-63. PubMed ID: 16208172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent Subacute Thyroiditis and Graves' Disease After COVID-19: A Case Report.
    Nham E; Song E; Hyun H; Seong H; Yoon JG; Noh JY; Song JY; Cheong HJ; Kim WJ
    J Korean Med Sci; 2023 May; 38(18):e134. PubMed ID: 37158771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report.
    Yasuda S; Suzuki S; Yanagisawa S; Morita H; Haisa A; Satomura A; Nakajima R; Oikawa Y; Inoue I; Shimada A
    BMC Endocr Disord; 2023 Mar; 23(1):54. PubMed ID: 36879263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of (99m)Tc-pertechnetate thyroid scintigraphy in radioiodine therapy in a cohort of Chinese Graves' disease patients: a pilot clinical study.
    Hou H; Hu S; Fan R; Sun W; Zhang X; Tian M
    Biomed Res Int; 2015; 2015():974689. PubMed ID: 25879041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch of F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) and Tc-99m pertechnetate thyroid scan in subacute thyroiditis.
    Lambert M; Jouret F; Lonneux M; Jamar F
    Acta Clin Belg; 2008; 63(3):209-10. PubMed ID: 18714854
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies of human peripheral blood mononuclear cells (PBMC) from patients with subacute thyroiditis in severe combined immunodeficient (SCID) mice: less production of human interferon gamma than that seen for Graves' disease.
    Yoshikawa N; Arreaza G; Morita T; Mukuta T; Resetkova E; Miller N; Volpé R
    Horm Metab Res; 1994 Sep; 26(9):419-23. PubMed ID: 7835825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technetium-99m tetrofosmin imaging in patients with subacute thyroiditis.
    Hiromatsu Y; Ishibashi M; Miyake I; Nonaka K
    Eur J Nucl Med; 1998 Oct; 25(10):1448-52. PubMed ID: 9818287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake.
    Ikekubo K; Hino M; Ito H; Koh T; Ishihara T; Kurahachi H; Kasagi K; Hidaka A; Mori T
    Ann Nucl Med; 1990 Jul; 4(2):43-8. PubMed ID: 2171608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.